1-(4-bromophenyl)-2-(4-nitrophenoxy)ethanone, 95.0%, 5g

6-Bromo[1,2,4]triazolo[1,5-a]pyridine-8-carbonitrile, 5g

(S)-3-(4-Cyclopropyl-2,5-dioxoimidazolidin-4-yl)propanoic acid, 98%, 25mg

3,3-DIFLUOROPIPERIDINE-4,4-DIOL HCL, 95.0%, 100mg

4-Morpholinoaniline, 98.0%, 1g

tert-Butyl 2-oxo-2,5-dihydro-1H-pyrrole-1-carboxylate, 95.0%, 25g

tert-Butyl n-(1,2,3,4-tetrahydroquinolin-5-yl)carbamate, 97%, 250mg

Octahydro-2H-pyrano[3,2-c]pyridine, 98%, 1g

tert-Butyl (3S,4S)-3-hydroxy-4-(methylamino)piperidine-1-carboxylate, 98%, 250mg

Plan PLMi 5x/0.12 objectif IOS corrigé à l'infini. Distance de travail 26,1 mm

2,4,6-Trifluoroaniline, 97.0%, 25g

3-(S-Methylsulfonimidoyl)benzoic acid, 100mg

2-(2-Oxo-3,4-dihydroquinolin-1(2H)-yl)acetic acid, 96%, 100mg